Prof. Eitan Fibach is the head of a research group at the Department
of Hematology, Hadassah University Hospital, and a full professor at the Department
of Developmental Biology, Hebrew University, Israel. At the hospital, patients with
all kinds of haematological diseases, such as leukaemias and lymphomas, blood-clotting
disorders and chronic anaemias, including about 100 patients with thalassaemia and
sickle cell anaemia, are taken care of. The service for thalassaemia patients includes
genetic counselling, prenatal diagnosis, blood transfusion, iron chelation, hydroxyurea
treatment and various symptomatic treatments, and bone marrow transplantation.
Prof. Fibach's research projects include
- therapy of patients with beta-thalassaemia and sickle cell anaemia by stimulation
of endogenous fetal haemoglobin production
- the involvement of oxidative stress in the pathology of beta-thalassaemia and the
potential benefit of antioxidants.